ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Concepts For New Radiation Studies

June 12, 1987

Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting

June 25, 2010

Spring Meetings Will Concentrate Everyone In New Orleans – Except The Nurses

March 25, 1988

In Brief: House Appropriations Bill Marked Up, Lid Clamped On; Wells Named DCT Board Chairman

July 6, 1984

Gallo, Collaborators Map Entire Genetic Structure Of HTLV-III

January 25, 1985

ACCC Members To Lobby, Hear Discussion on Oncology Unit

January 6, 1978